|
|
||||||||
ORIGINAL RESEARCH |
From the Division of Immunology and Infectious Diseases, Department of Obstetrics and Gynecology, Weill Medical College of Cornell University, New York, New York; the Department of Gynecology and Obstetrics, University of Campinas, São Paulo, Brazil; Hospital das Clínicas, São Paulo, Brazil; and the Federal University of Bahia, Salvador, Brazil.
Address reprint requests to: Paulo Giraldo, MD Division of Immunology and Infectious Diseases Department of Obstetrics and Gynecology Weill Medical College of Cornell University 515 East 71st Street New York, NY 10021 E-mail: switkin{at}mail.med.cornell.edu
Objective: The asymptomatic carriage of Candida in the vagina of women with a history of recurrent vulvovaginal candidiasis was compared with that of women with no such history.
Methods: Vaginal swabs from 50 women with a history of recurrent vulvovaginal candidiasis and 45 women with one or fewer episodes of candidal vaginaitis within the past 12 months were evaluated for Candida by wet mount/Gram stain, culture, and polymerase chain reaction (PCR). All women were asymptomatic for at least 30 days.
Results: Candida was identified in 28 women by PCR, in 14 women by culture, and in 13 women by wet mount/Gram stain. Candida was identified by PCR in a similar proportion of patients with previous recurrent vulvovaginal candidiasis (30%) and in controls (28.8%). However, Candida was identified by culture in more women with previous recurrent vulvovaginal candidiasis (22%) than in controls (6.6%, P = .04); it also was identified by wet mount/Gram stain in more women with recurrent vulvovaginal candidiasis (22%) than in controls (4.4%, P = .01). For the recurrent vulvovaginal candidiasis patients, culture and wet mount/Gram stain had a sensitivity of 66.6% compared with PCR. For the controls, the sensitivity of the two former assays relative to PCR was only 15.3%.
Conclusion: Women with a history of recurrent vulvovaginal candidiasis have more easily detectable Candida in their vagina, even when asymptomatic, than do other women. A relative inefficiency in regulating the proliferation of Candida in the vagina may increase susceptibility to periodic symptomatic recurrences.
This article has been cited by other articles:
![]() |
P. C. Giraldo, O. Babula, A. K. S. Goncalves, I. M. Linhares, R. L. Amaral, W. J. Ledger, and S. S. Witkin Mannose-Binding Lectin Gene Polymorphism, Vulvovaginal Candidiasis, and Bacterial Vaginosis Obstet. Gynecol., May 1, 2007; 109(5): 1123 - 1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
D J White and A Vanthuyne Vulvovaginal candidiasis Sex. Transm. Inf., December 1, 2006; 82(suppl_4): iv28 - iv30. [Full Text] [PDF] |
||||
![]() |
M. A. Turrentine Single-Dose Fluconazole for Vulvovaginal Candidiasis: Impact on Prothrombin Time in Women Taking Warfarin Obstet. Gynecol., February 1, 2006; 107(2): 310 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
D J White, A Vanthuyne, P M Wood, and J G Ayres Zafirlukast for severe recurrent vulvovaginal candidiasis: an open label pilot study Sex. Transm. Inf., June 1, 2004; 80(3): 219 - 222. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |